What the company does
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and markets protein and small molecule therapies, and orphan indications targeting inflammation, complement-mediated diseases, central nervous system (CNS) disorders, and system-related diseases. immunological. The company is headquartered in Seattle, Washington.
What the weekly tape is saying
OMER closed the latest completed week at 8.73 USD. The 4-week return is -28.7% and the 12-week return is -20.6%. Trend Signal is inactive, Market Dynamics is -0.60. Setup signature: Risk-first tape with a 22/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 11.73 USD
- Vs Trend Line
- -25.5%
- Fair Value
- 6.20 USD
- Vs Fair Value
- 41.0%
- 52W High
- 17.65 USD
- 52W Low
- 2.95 USD
- Drawdown
- -50.5%
- Range Position
- 39.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 31
- 52W Active Breadth
- 59.6%
- Sector Scope
- US Healthcare
- Sector Rank
- 951 of 1038
- Sector Percentile
- 8.4%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.60
- 4W MD Change
- -231.2%
- Relative Strength
- -14.33
- 4W RS Change
- -151.8%
- Expectation
- Negative
- Probability
- 43.24%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 13.2M
- 13W Average
- 7.2M
- 52W Average
- 10.1M
- Vs 13W
- 1.8x
- Vs 52W
- 1.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 9.4%
- 52W Volatility
- 17.6%
- Upside Weeks
- 23
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 14.2% / -6.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 799.0M
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 8.73 USD | -10.8% | 11.73 USD | 6.20 USD | -0.60 | -14.33 | 13.2M | Off |
| 5 Jun 2026 | 9.79 USD | -11.3% | 11.70 USD | 6.18 USD | -0.31 | -1.01 | 8.7M | Off |
| 29 May 2026 | 11.04 USD | -3.7% | 11.59 USD | 6.16 USD | 0.01 | 7.60 | 9.3M | On |
| 22 May 2026 | 11.46 USD | -6.4% | 11.47 USD | 6.14 USD | 0.29 | 16.37 | 7.0M | On |
| 15 May 2026 | 12.25 USD | -13.3% | 11.34 USD | 6.10 USD | 0.46 | 27.64 | 11.0M | On |
| 8 May 2026 | 14.13 USD | -6.2% | 11.20 USD | 6.06 USD | 0.45 | 49.10 | 4.0M | On |
| 1 May 2026 | 15.06 USD | 11.3% | 10.87 USD | 6.01 USD | 0.11 | 69.40 | 6.4M | On |
| 24 Apr 2026 | 13.53 USD | 0.7% | 10.52 USD | 5.95 USD | -0.28 | 56.28 | 5.2M | On |
| 17 Apr 2026 | 13.44 USD | 17.0% | 10.22 USD | 5.90 USD | -0.65 | 59.98 | 5.8M | On |
| 10 Apr 2026 | 11.49 USD | 5.4% | 9.91 USD | 5.85 USD | -0.95 | 46.39 | 5.7M | On |
| 2 Apr 2026 | 10.90 USD | 10.3% | 9.66 USD | 5.81 USD | -0.96 | 45.92 | 9.4M | On |
| 27 Mar 2026 | 9.88 USD | -10.2% | 9.44 USD | 5.78 USD | -0.94 | 37.92 | 4.2M | On |
| 20 Mar 2026 | 11.00 USD | -1.7% | 9.25 USD | 5.74 USD | -0.81 | 48.47 | 3.9M | On |
| 13 Mar 2026 | 11.19 USD | -3.0% | 9.03 USD | 5.70 USD | -0.68 | 48.04 | 3.9M | On |